Review
Accepted on 27 Apr 2026
Limited benefits of neoadjuvant therapy in the improvement of the R0 resection rate and overall survival in patients with resectable or locally advanced PDAC in randomized controlled trials
in Gastroenterology
Review
Accepted on 27 Apr 2026
in Gastroenterology
Perspective
Accepted on 27 Apr 2026
in Precision Medicine
Brief Research Report
Accepted on 27 Apr 2026
in Health Workforce
Original Research
Accepted on 27 Apr 2026
in Cancer Genetics and Oncogenomics
Original Research
Accepted on 27 Apr 2026
in Cancer Immunity and Immunotherapy
Mini Review
Accepted on 27 Apr 2026
in Ethnopharmacology
Original Research
Accepted on 27 Apr 2026
in T Cell Biology
Perspective
Accepted on 27 Apr 2026
in Health Policy and Management
Original Research
Accepted on 27 Apr 2026
in Health Technology Implementation
Review
Accepted on 27 Apr 2026
in Cancer Immunity and Immunotherapy
Brief Research Report
Accepted on 27 Apr 2026
in Psychology of Language
Brief Research Report
Accepted on 27 Apr 2026
in Implementation Science
Original Research
Accepted on 27 Apr 2026
in Reproduction
Original Research
Accepted on 27 Apr 2026
in Plant Breeding
Original Research
Accepted on 27 Apr 2026
in Patient Safety
Original Research
Accepted on 27 Apr 2026
in Pediatric Gastroenterology, Hepatology and Nutrition